Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis

Arthritis Research and Therapy

Volumn 15, Issue 6, 2013, Pages

  de Munter, Wouter ^a   Blom, Arjen B ^a   Helsen, Monique M ^a   Walgreen, Birgitte ^a   van der Kraan, Peter M ^a   Joosten, Leo A B ^a   van den Berg, Wim B ^a   van Lent, Peter L E M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CALGRANULIN A; CHOLESTEROL; CLOSTRIDIOPEPTIDASE A; GROWTH FACTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE DEGENERATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; KNEE OSTEOARTHRITIS; MACROPHAGE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOPHYTE; PATHOGENESIS; SIGNAL TRANSDUCTION; SYNOVIUM; TIBIA; WEIGHT GAIN; ANIMAL; ANIMAL FOOD; C57BL MOUSE; CHOLESTEROL INTAKE; EXPERIMENTAL ARTHRITIS; HETEROTOPIC OSSIFICATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; OSTEOARTHRITIS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMAL FEED; ANIMALS; ARTHRITIS, EXPERIMENTAL; CHOLESTEROL; CHOLESTEROL, DIETARY; FEMALE; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSSIFICATION, HETEROTOPIC; OSTEOARTHRITIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LDL; SYNOVIAL MEMBRANE;

EID: 84886739311     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4367     Document Type: Article

References (51)

1. Felson DT, Chaisson CE. Understanding the relationship between body weight and osteoarthritis. Baillieres Clin Rheumatol 1997, 11:671-681. 10.1016/S0950-3579(97)80003-9, 9429730.
2. Velasquez MT, Katz JD. Osteoarthritis: another component of metabolic syndrome?. Metab Syndr Relat Disord 2010, 8:295-305. 10.1089/met.2009.0110, 20367223.
3. Hunter DJ, Felson DT. Osteoarthritis. BMJ 2006, 332:639-642. 10.1136/bmj.332.7542.639, 1403209, 16543327.
4. Yusuf E, Nelissen RG, Ioan-Facsinay A, Stojanovic-Susulic V, DeGroot J, van Osch G, Middeldorp S, Huizinga TW, Kloppenburg M. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 2010, 69:761-765. 10.1136/ard.2008.106930, 19487215.
5. Katz JD, Agrawal S, Velasquez M. Getting to the heart of the matter: osteoarthritis takes its place as part of the metabolic syndrome. Curr Opin Rheumatol 2010, 22:512-519. 10.1097/BOR.0b013e32833bfb4b, 20592604.
6. Carman WJ, Sowers M, Hawthorne VM, Weissfeld LA. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol 1994, 139:119-129.
7. Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord 2008, 9:132. 10.1186/1471-2474-9-132, 2573886, 18831740.
8. Koskinen J, Magnussen CG, Wurtz P, Soininen P, Kangas AJ, Viikari JS, Kahonen M, Loo BM, Jula A, Ahotupa M, Lehtimäki T, Ala-Korpela M, Juonala M, Raitakari OT. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular risk in Young Finns study. Eur J Prev Cardiol 2012, 19:1296-1303. 10.1177/1741826711425343, 21960651.
9. Mishra R, Singh A, Chandra V, Negi MP, Tripathy BC, Prakash J, Gupta V. A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis. Rheumatol Int 2012, 32:2377-2382. 10.1007/s00296-011-1964-1, 21644045.
10. Oliviero F, Lo Nigro A, Bernardi D, Giunco S, Baldo G, Scanu A, Sfriso P, Ramonda R, Plebani M, Punzi L. A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides. Clin Chim Acta 2012, 413:303-307. 10.1016/j.cca.2011.10.019, 22037510.
11. Badimon L, Storey RF, Vilahur G. Update on lipids, inflammation and atherothrombosis. Thromb Haemost 2011, 105:S34-S42. 10.1160/THS10-11-0717, 21479344.
12. Badimon L, Vilahur G. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos. Ann N Y Acad Sci 2012, 1254:18-32. 10.1111/j.1749-6632.2012.06480.x, 22548566.
13. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983, 24:1070-1076.
14. James MJ, van Reyk D, Rye KA, Dean RT, Cleland LG, Barter PJ, Jessup W. Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized. Lipids 1998, 33:1115-1121. 10.1007/s11745-998-0313-8, 9870907.
15. Groeneweg M, Kanters E, Vergouwe MN, Duerink H, Kraal G, Hofker MH, de Winther MP. Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL. J Lipid Res 2006, 47:2259-2267. 10.1194/jlr.M600181-JLR200, 16840796.
16. van Tits LJ, Stienstra R, van Lent PL, Netea MG, Joosten LA, Stalenhoef AF. Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Kruppel-like factor 2. Atherosclerosis 2011, 214:345-349. 10.1016/j.atherosclerosis.2010.11.018, 21167486.
17. Jiang Y, Wang M, Huang K, Zhang Z, Shao N, Zhang Y, Wang W, Wang S. Oxidized low-density lipoprotein induces secretion of interleukin-1beta by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation. Biochem Biophys Res Commun 2012, 425:121-126. 10.1016/j.bbrc.2012.07.011, 22796220.
18. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 1998, 334:9-13. 1219654, 9693095.
19. Murphy JE, Vohra RS, Dunn S, Holloway ZG, Monaco AP, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. Oxidised LDL internalisation by the LOX-1 scavenger receptor is dependent on a novel cytoplasmic motif and is regulated by dynamin-2. J Cell Sci 2008, 121:2136-2147. 10.1242/jcs.020917, 18544637.
20. Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg WB. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010, 62:647-657.
21. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 2006, 8:R187. 10.1186/ar2099, 1794533, 17177994.
22. Blom AB, van Lent PL, Libregts S, Holthuysen AE, van der Kraan PM, van Rooijen N, van den Berg WB. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007, 56:147-157. 10.1002/art.22337, 17195217.
23. Rogers J, Shepstone L, Dieppe P. Bone formers: osteophyte and enthesophyte formation are positively associated. Ann Rheum Dis 1997, 56:85-90. 10.1136/ard.56.2.85, 1752321, 9068279.
24. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 1998, 6:306-317. 10.1053/joca.1998.0129, 10197165.
25. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 2000, 8:25-33. 10.1053/joca.1999.0267, 10607496.
26. Blom AB, van Lent PL, Holthuysen AE, van der Kraan PM, Roth J, van Rooijen N, van den Berg WB. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2004, 12:627-635. 10.1016/j.joca.2004.03.003, 15262242.
27. van Lent PL, Blom AB, van der Kraan P, Holthuysen AE, Vitters E, van Rooijen N, Smeets RL, Nabbe KC, van den Berg WB. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum 2004, 50:103-111. 10.1002/art.11422, 14730606.
28. Getz GS, Reardon CA. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:1104-1115. 10.1161/ATVBAHA.111.237693, 3331926, 22383700.
29. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993, 92:883-893. 10.1172/JCI116663, 294927, 8349823.
30. van der Kraan PM, Vitters EL, van Beuningen HM, van de Putte LB, van den Berg WB. Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. J Exp Pathol 1990, 71:19-31.
31. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006, 14:13-29. 10.1016/j.joca.2005.07.014, 16242352.
32. Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 2010, 18:S17-S23.
33. van Tits LJ, Demacker PN, de Graaf J, Hak-Lemmers HL. Stalenhoef AF: alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals. Am J Clin Nutr 2000, 71:458-464.
34. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
35. van Lent PL, Blom AB, Schelbergen RF, Sloetjes A, Lafeber FP, Lems WF, Cats H, Vogl T, Roth J, van den Berg WB. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum 2012, 64:1466-1476. 10.1002/art.34315, 22143922.
36. Tan AL, Grainger AJ, Tanner SF, Shelley DM, Pease C, Emery P, McGonagle D. High-resolution magnetic resonance imaging for the assessment of hand osteoarthritis. Arthritis Rheum 2005, 52:2355-2365. 10.1002/art.21210, 16052535.
37. Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, Kim TS. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J Biol Chem 2000, 275:32681-32687.
38. Mahley RW, Innerarity TL, Rall SC, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984, 25:1277-1294.
39. Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol 2009, 29:431-438. 10.1161/ATVBAHA.108.179564, 2740366, 19299327.
40. Spady DK, Meddings JB, Dietschy JM. Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster. J Clin Invest 1986, 77:1474-1481. 10.1172/JCI112460, 424548, 3700649.
41. Mooney RA, Sampson ER, Lerea J, Rosier RN, Zuscik MJ. High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury. Arthritis Res Ther 2011, 13:R198. 10.1186/ar3529, 3334649, 22152451.
42. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences. Ann Rheum Dis 1994, 53:593-600. 10.1136/ard.53.9.593, 1005411, 7979598.
43. Yang H, Mohamed AS, Zhou SH. Oxidized low density lipoprotein, stem cells, and atherosclerosis. Lipids Health Dis 2012, 11:85. 10.1186/1476-511X-11-85, 3475066, 22747902.
44. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002, 1585:213-221. 10.1016/S1388-1981(02)00343-8, 12531556.
45. Chu L, Hao H, Luo M, Huang Y, Chen Z, Lu T, Zhao X, Verfaillie CM, Zweier JL, Liu Z. Ox-LDL modifies the behaviour of bone marrow stem cells and impairs their endothelial differentiation via inhibition of Akt phosphorylation. J Cell Mol Med 2011, 15:423-432. 10.1111/j.1582-4934.2009.00948.x, 19863696.
46. Lu T, Parthasarathy S, Hao H, Luo M, Ahmed S, Zhu J, Luo S, Kuppusamy P, Sen CK, Verfaillie CM, Tian J, Liu Z. Reactive oxygen species mediate oxidized low-density lipoprotein-induced inhibition of oct-4 expression and endothelial differentiation of bone marrow stem cells. Antioxid Redox Signal 2010, 13:1845-1856. 10.1089/ars.2010.3156, 2971633, 20836655.
47. Tie G, Yan J, Yang Y, Park BD, Messina JA, Raffai RL, Nowicki PT, Messina LM. Oxidized low-density lipoprotein induces apoptosis in endothelial progenitor cells by inactivating the phosphoinositide 3-kinase/Akt pathway. J Vasc Res 2010, 47:519-530. 10.1159/000313879, 2945270, 20431300.
48. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Gene Dev 2000, 14:163-176. 316345, 10652271.
49. Ishikawa M, Ito H, Akiyoshi M, Kume N, Yoshitomi H, Mitsuoka H, Tanida S, Murata K, Shibuya H, Kasahara T, Kakino A, Fujita Y, Sawamura T, Yasuda T, Nakamura T. Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis. Arthritis Rheum 2012, 64:1024-1034. 10.1002/art.33452, 22076918.
50. Blaney Davidson EN, Vitters EL, van Beuningen HM, van de Loo FA, van den Berg WB, van der Kraan PM. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 2007, 56:4065-4073. 10.1002/art.23034, 18050218.
51. Simopoulou T, Malizos KN, Tsezou A. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes. Clin Exp Rheumatol 2007, 25:605-612.